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Abstract
One major unanswered question in neuroscience is how the brain transitions between conscious and unconscious states.
General anesthetics offer a controllable means to study these transitions. Induction of anesthesia is commonly attributed to
drug-induced global modulation of neuronal function, while emergence from anesthesia has been thought to occur
passively, paralleling elimination of the anesthetic from its sites in the central nervous system (CNS). If this were true, then
CNS anesthetic concentrations on induction and emergence would be indistinguishable. By generating anesthetic dose-
response data in both insects and mammals, we demonstrate that the forward and reverse paths through which anesthetic-
induced unconsciousness arises and dissipates are not identical. Instead they exhibit hysteresis that is not fully explained by
pharmacokinetics as previously thought. Single gene mutations that affect sleep-wake states are shown to collapse or
widen anesthetic hysteresis without obvious confounding effects on volatile anesthetic uptake, distribution, or metabolism.
We propose a fundamental and biologically conserved concept of neural inertia, a tendency of the CNS to resist behavioral
state transitions between conscious and unconscious states. We demonstrate that such a barrier separates wakeful and
anesthetized states for multiple anesthetics in both flies and mice, and argue that it contributes to the hysteresis observed
when the brain transitions between conscious and unconscious states.
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Introduction
Alternating activity in neuronal networks is responsible for the
daily fluctuation between states of conscious wakefulness and the
unconsciousness associated with natural sleep [1]. As with wake
and sleep, consciousness and anesthetic-induced unconsciousness
are bistable, as subjects exist in only one of the mutually exclusive
states at a time [2,3]. Mathematical models of bistable systems
predict the existence of hysteresis between the stable states [3].
Hysteresis is defined by the existence of distinct forward and
reverse paths between the two stable states. The area enclosed by
the hysteresis loop can be measured and often carries physical
significance, for example the work, heat, or energy lost, which are
respectively determined by integrating area under the pulmonary
pressure-volume, force-length, or magnetization-magnetic field
strength hysteresis loops [4,5,6].
Hysteresis in anesthetic-induced unconsciousness has been theo-
rized using mathematical models of the transitions to and from
anesthetic-induced unconsciousness [7]. At the central nervous
system level, anesthetics exert their hypnotic effects in part by
interacting with neuronal circuits that participate in the control of
sleep and wakefulness [8,9,10,11]. Hence, one might expect
anesthetics to influence the hysteresis predicted to exist in the flip-
flop switch that regulates states of natural sleep and wakefulness [2,3].
However, rather than embracing hysteretic models of anesthetic-
induced disruption and subsequent restoration of consciousness,
existing models commonly collapse the hysteresis loop (Figure 1) into
a single sigmoidal curve using pharmacokinetics to invoke an
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11903idealized anesthetic concentration at its effect site [12,13,14].
Nonetheless, evidence persists to suggest path-dependence of the
transitions to and from unconscious states [14].
In this manuscript, we demonstrate that hysteresis in the onset
and offset of anesthetic-induced unconsciousness cannot be fully
explained by pharmacokinetics. We postulate that the area under
the anesthetic dose-response hysteresis loop serves as a useful
metric to unmask an intrinsic property of the central nervous
system, namely the inherent resistance to changes in arousal state,
which we term neural inertia. In two different species, we also
present evidence that the barrier separating conscious and
unconscious states is amenable to genetic and pharmacologic
manipulation and is modulated by specific arousal-promoting
mechanisms. The finding that specific gene products can affect the
barrier size and thus the magnitude of hysteresis further excludes a
pharmacokinetic explanation. In addition, genes and circuits
related to arousal and sleep are implicated in the control of neural
inertia. Thus, it is likely that understanding the mechanisms
underlying neural inertia will provide insights into the regulation
of sleep as well as states in which return of consciousness is
pathologically impaired [15].
Results
Wild-type mice exposed to volatile anesthetics exhibit
hysteresis between induction and emergence
By definition, anesthetic induction in mice occurs at the drug
concentration at which the righting reflex is lost, whereas emergence
occurs at the concentration at which the righting reflex returns.
The EC50 for induction of halothane is more than 2.5 times that
of the EC50 for emergence (Figure 2A, Table 1). Though the
difference is smaller in magnitude, the EC50 for induction of
isoflurane in mice is also significantly greater than the EC50
for emergence (Figure 2B, Table 1). To rule out an exclusive
pharmacokinetic explanation, we determined the concentration of
the anesthetic gases in brain at induction and emergence. Indeed,
brain halothane and isoflurane concentrations at the EC50 for
induction are always significantly greater than at emergence
(Figure 2C). Because the central anesthetic concentration at
the EC50 for induction exceeds that for the EC50 at emergence,
anesthetic induction and emergence display path dependence
(Figure 1). Moreover, for both anesthetics, the Hill slopes are also
significantly greater for induction than emergence (Figure 2,
Figure 1. Schematic Data Demonstrating Path-Dependent and Path-Independent State Transitions. (A) Hysteresis defines path-
dependent processes. The solid black curve represents a population of individuals entering the state of unconsciousness as a function of anesthetic
dose. The dashed black curve represents the same population returning to a state of wakefulness as a function of anesthetic dose. (B) In the absence
of hysteresis, the forward and reverse paths are superimposed (thick gray curve). Modeling studies of anesthetic-induced unconsciousness often
collapse the hysteresis into a single curve to create path-independence. Experimental determination of arousal state at the steady-state anesthetic
dose(s) half way between the top and bottom asymptotes, the EC50, can easily distinguish path-dependent from path-independent processes. In the
former, the EC50 for induction and emergence differ significantly, whereas in the latter they are statistically indistinguishable.
doi:10.1371/journal.pone.0011903.g001
Figure 2. Neural Inertia In Wild Type Mice. Within the shaded area, subjects will be awake or anesthetized depending upon their previous state
of arousal. This area represents a resistance to change in arousal state and graphically depicts neural inertia. (A) Halothane dose-response curve in
wild-type mice for induction and emergence. (B) Isoflurane dose-response in wild-type mice. (C) One-way ANOVA with post-test Bonferroni multiple
comparisons correction indicates that the residual volatile anesthetic in mouse brain at the corresponding EC50 for emergence is always significantly
less than that at the EC50 for induction.
**p,0.01. (D) Neural inertia in wild-type mice exposed to halothane (red) or isoflurane (purple). X-axis in A and
B corresponds to the log of the inhaled anesthetic concentration. All neural inertia bar graphs carry units of log[Anesthetic (%atm)]. Filled squares and
solid curve denote induction. Open squares and dashed curve denote emergence.
doi:10.1371/journal.pone.0011903.g002
Behavioral State Barrier
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consistent with the notion that emergence from anesthesia is not
the mirror opposite process of induction.
Neural inertia provides a quantitative measurement of
the barrier separating states of anesthesia and
wakefulness
While significant differences exist in the concentration of
anesthetic at which half of the test population enter and exit the
state of anesthesia (induction EC50.emergence EC50), a more
comprehensive description is shown graphically by the shaded
area bracketed between the solid induction and dashed emergence
curves (Figure 2A–B). Integration of both curves over the range of
the induction curve’s EC1 through the emergence curve’s EC99
(Figure S1, Appendix S1) yields an area that is a quantitative
measure of resistance to transitions between arousal states, which
we define as neural inertia (Figure 2D).
Wild-type Drosophila exhibit hysteresis in their behavioral
state transitions
To determine if barriers impeding state transitions are
conserved across evolution, we examined the effects of anesthetics
on Drosophila, which have proven to be a useful model organism for
studying anesthetic mechanisms [16,17,18,19]. We developed a
novel, high throughput assay to measure induction and emergence
from anesthesia in flies. Anesthetic responsiveness in this assay is
determined during the evening activity peak, when flies demon-
strate consolidated wakefulness (Figure 3A–B) [20,21]. On the
experimental day, flies are exposed to stepwise increasing and then
decreasing concentrations of an anesthetic in air. Control flies are
exposed to an identical flow of air alone. Activity ceases in the
population exposed to anesthetic and then gradually resumes upon
emergence (Figure 3C–D). On the subsequent day, there are no
gross differences in activity between flies previously exposed to an
inhaled anesthetic or to air (Figure 3E–F).
Anesthetic induction in our assay is defined as the lowest
concentration at which movement ceases for five or more minutes,
whereas emergence is defined as the highest concentration at which
movement resumes (Figure 4A–B). A five-minute immobility bout
was chosen based upon definitions of Drosophila sleep [20,21]. With
these definitions, the EC50 for induction of halothane anesthesia in
Iso31 wild-type flies is more than 2.5 times that for emergence
(Figure 4A, Table 1). Similarly, the EC50 for induction of
isoflurane anesthesia in Iso31 flies is significantly greater than that
of emergence (Figure 4B, Table 1). Once again, Hill slopes for
induction are significantly greater than for emergence (Table 1).
The fly was chosen as a model organism in part because the lower
diffusion barriers (as compared to a mammal) and hence faster
equilibration renders a pharmacokinetic explanation for hysteresis
unlikely. Nevertheless, were a pharmacokinetic confound present
in the fly, it would be most obvious for the most lipid soluble
compound, halothane. Therefore, we measured whole fly
halothane concentration at the EC50 for induction and emergence
and confirmed a significantly lower amount of halothane present
at emergence (Figure 4C), further refuting an exclusively
pharmacokinetic explanation. Experiments performed in a second
strain of wild-type RC1 flies, which carry the wild type w allele,
yield similar data to the Iso31 strain, which carry the w
1118 allele
previously shown to influence anesthetic sensitivity [22], for both
halothane and isoflurane (Figure S2).
Barrier separating an anesthetized state from
wakefulness can be manipulated genetically and
pharmacologically in mice
Based upon pharmacologic and lesion studies that impair
adrenergic signaling and modulate supra-hypnotic anesthetic
endpoints [23,24,25], we considered the adrenergic system as a
candidate that might affect neural inertia. Therefore, we tested
dopamine ß-hydroxylase (Dbh) null mice, which are devoid of
norepinephrine and epinephrine, and compared them with Dbh
heterozygous sibling controls shown previously to have normal
catecholamine levels [26]. As predicted from previous studies
[23,24,25], Dbh null mice exhibit hypersensitivity to induction by
isoflurane. However, their most striking phenotype is a dramatic
increase in neural inertia, due to a profoundly altered threshold for
emergence (Figure 5A).
L-DOPS is a synthetic amino acid that can be converted to
norepinephrine by aromatic L-amino acid decarboxylase in Dbh
null mice. By pairing L-DOPS with a peripheral aromatic L-
amino acid decarboxylase inhibitor, we achieve a CNS-specific
acute rescue of adrenergic signaling in Dbh null mice while leaving
all other peripheral tissues devoid of both epinephrine and
norepinephrine [26]. Such CNS-specific rescue restores neural
inertia to control levels by normalizing the EC50 and Hill slopes
for induction and emergence. Conversely, injection of a vehicle
control into Dbh null mice is ineffective (Figure 5B–C, Table 2).
Together these experiments indicate that norepinephrine acts in
the CNS to overcome the barrier opposing anesthetic emergence.
Table 1. Best-fit parameters for volatile anesthetic studies in wild type mice and flies.
Mouse Fly
Halothane Isoflurane Halothane Isoflurane
Induction Emergence Induction Emergence Induction Emergence Induction Emergence
EC50 (%atm) 0.77 0.27 0.90 0.83 0.52 0.22 0.43 0.29
95% C.I. (%atm) 0.76–0.77 0.25–0.28 0.89–0.90 0.82–0.84 0.50–0.54 0.19–0.26 0.41–0.44 0.28–0.31
Hill slope 230.9 23.7 226.8 216.3 211.8 23.4 29.0 25.1
95% C.I. (%atm) 238.2 to 223.7 24.3 to 23.1 230.4 to 223.2 219.0 to 213.6 215.5 to 28.1 25.2 to 21.6 211.5 to 26.6 26.3 to 23.9
Top 100 100 100 100 99 63 98 69
95% C.I. Top N.A. N.A. N.A. N.A. 89–100 56–71 92–100 62–76
Top is set to 100% in mice.
doi:10.1371/journal.pone.0011903.t001
Behavioral State Barrier
PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11903Figure 3. Drosophila Actograms of Locomotor Behavior. Wild-type Iso31 flies entrained to a 12:12 hour light (yellow):dark (gray) schedule
display evening peak activity in pressurized air control (black) and isoflurane (purple) groups. One day prior to gas exposure, activity patterns are
similar in the (A) air control group and (B) isoflurane group. On the experimental day, the duration of exposure to pressurized air with or without
anesthetic gas is indicated by the thin horizontal black bar. (C) Activity pattern remains unchanged in the air control group. (D) Induction of
anesthesia is marked by an abrupt cessation of activity in the isoflurane group, while emergence is marked by the resumption of activity. On the day
following gas exposure, normal evening activity patterns are observed for flies previously exposed to (E) pressurized air without any anesthetic and
(F) pressurized air containing isoflurane.
doi:10.1371/journal.pone.0011903.g003
Figure 4. Neural Inertia In Wild Type Drosophila. (A) Halothane dose-response in wild-type Iso31 flies. (B) Isoflurane dose-response in wild-type
Iso31 flies. (C) Unpaired t-test demonstrates that the residual halothane in a population of whole flies obtained at the corresponding EC50 for
emergence is likewise significantly less than that at the EC50 for induction. (D) Neural inertia of wild type Iso31 flies. X-axis in A and B corresponds to
the log of the inhaled anesthetic concentration. Halothane is shown in red shading while isoflurane is shown in purple. Induction denoted by filled
circles and solid curves, emergence by open circles and dashed curves.
*p,0.05.
doi:10.1371/journal.pone.0011903.g004
Behavioral State Barrier
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wakefulness is decreased in Drosophila Shaker potassium
channel mutants
Norepinephrine is a potent arousal-promoting stimulus in
mammals. To determine if mechanisms that regulate arousal in
the fly also affect behavioral state barriers, we tested one such
mechanism. In Drosophila, the Shaker potassium channel (Sh)
decreases neural activity and promotes sleep. Consequently, loss
of function Sh mutants show reduced sleep and increased arousal.
Such mutants also exhibit resistance to anesthetic induction
[27,28,29]. We therefore studied flies carrying the minisleep Shaker
mutant allele (Sh
mns) to assess their barrier to state changes.
Consistent with published results, Sh
mns mutants exhibit significant
resistance to induction of anesthesia by isoflurane when compared
to sibling controls. However, the most striking phenotype of these
flies is reduced neural inertia (Figure 6A–B). A significantly greater
fraction of Sh
mns mutant flies emerge during the course of
downward anesthetic titration as compared to their sibling
controls. This behavioral change is largely due to a rightward
shift in the EC50 for emergence, which translates into collapsed
hysteresis, and is measured by reduced neural inertia in Sh
mns
mutants. The Sh
mns mutant flies’ EC50 for emergence exceeds the
EC50 for induction of their wild type sibling controls (Figure 6A
and Table 3).
Discussion
Using general anesthetics, we establish the existence of a
fundamental and previouslyunrecognizedpropertyof neuralcircuits
to resist state changes in arousal. We demonstrate that hysteresis
between the forward and reverse paths through which the state of
anesthesia arises and dissipates cannot be explained solely by
pharmacokinetics. Rather, we report novel experimental evidence
for a first-order phase transition to and from unconscious states
[7,30]. Once a population of individuals undergoes a transition from
wakefulness to anesthetic-induced unconsciousness, that population
exhibits resistance to the return of the wakeful state. We use the term
neural inertia to describe the experimental representation of the
behavioral state barrier and propose that it must dissipate prior to
anesthetic emergence and normalization of cognitive function.
Hysteresisbetweenanestheticinductionand emergencesuggeststhat
the neural substrates modulating arousal state exhibit memory.
While the identity of these neural substrates remains unknown, the
difference in neural inertia between animals anesthetized with
isoflurane and halothane is not altogether unexpected [31]. Two
anestheticsthathaveidenticalmolecularandneuronaltargetsshould
give rise to identical hysteresis. However, halothane and isoflurane
exhibit differences in protein binding, receptor modulation, and as
well as in their effects on neuronal circuits hypothesized to regulate
wakefulness [32,33,34,35].
Figure 5. Neural Inertia May Be Modified Both Genetically As Well As Pharmacologically. (A) Mice deficient for the enzyme dopamine ß-
hydroxylase (light gray squares) display hypersensitivity to induction (solid symbols, solid curve) of isoflurane anesthesia but a more significant
phenotype of delayed emergence (open gray squares, dashed curve) leading to a profound increase in neural inertia relative to their sibling controls
(black squares). (B) CNS-specific rescue of adrenergic signaling in these Dbh KO mice restores normal induction (solid black diamonds) and
emergence (open black diamonds) with respect to vehicle-treated Dbh KOs (shown in light gray). (C) One-way ANOVA with post-test Bonferroni
multiple comparisons correction indicates that neural inertia in Dbh KO mice is normalized only by CNS-specific rescue. X-axis in A and B corresponds
to the log of the inhaled anesthetic concentration.
*p,0.05.
doi:10.1371/journal.pone.0011903.g005
Table 2. Best fit parameters for isoflurane studies in Dbh null and heterozygous control mice.
Dbh hets Dbh KO Dbh KO + rescue Dbh KO + vehicle
Induction Emergence Induction Emergence Induction Emergence Induction Emergence
EC50 (%atm) 0.87 0.75 0.77 0.37 0.86 0.79 0.80 0.31
95% C.I.
(%atm)
0.86–0.87 0.73–0.77 0.76–0.78 0.35–0.38 0.85–0.88 0.76–0.82 0.77–0.83 0.29–0.34
Hill slope 230.3 28.8 223.0 23.8 222.7 26.5 216.9 24.8
95% C.I.
(%atm)
237.4 to 223.2 210.5 to 27.1 228.2 to 217.9 24.4 to 23.3 229.8 to 215.7 28.5 to 24.5 226.4 to 27.5 26.0 to 23.6
Top is set to 100% in mice.
doi:10.1371/journal.pone.0011903.t002
Behavioral State Barrier
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freezing temperatures for agar are 85uC and 40uC, respectively.
Like 60uC agar, a mouse or fly breathing 0.4% halothane might be
anesthetized or awake depending upon its previous state of
arousal. Another property of systems exhibiting hysteresis is the
presence of stable states in equilibrium. Hysteretic processes are
buffered against random or small fluctuations that might otherwise
precipitate a transition between states. These fortuitous features
are advantageous for clinical anesthesia, for once anesthetized,
subjects are unlikely to emerge spontaneously.
Our data also reveal a second property that differentiates
conscious ablation from its restoration. In wild type mice and flies,
the Hill slopes are steeper during anesthetic induction, indicating
less population variability from environmental or genetic sources in
comparison to anesthetic emergence. These results likely indicate
the underlying increased complexity of the conscious state and
suggest that it is more difficult to constitute, or reconstitute, a
conscious state than it is to disrupt the conscious wakeful state. Hill
slopes for emergence in Dbh null mice are significantly less than that
of their sibling controls, indicating that the loss of an arousal
promoting signal increases variability in emergence, perhaps as the
remaining loci struggle to reconstitute the wake state. Consistently,
Hill slopes for induction and emergence in Sh
mns flies are
indistinguishable. However as induction Hill slopes only trended
to be greater than emergence Hill slopes in Sh
mns sibling controls, it
is impossible to definitively assign the change in these slopes to the
Sh
mns alleleratherthantoanothergeneinthe geneticbackground of
both groups of flies.
The discovery of behavioral state barriers in two distantly
related phyla suggests that this property of nervous systems either
emerged at least twice independently or that it arose early in
evolution predating the split between arthropods and chordates.
Either way these barriers are present across phyla and likely exists
in humans as well. Despite non-steady-state conditions, clinical
evidence of hysteresis upon induction and emergence in humans
from general anesthesia is recognized, but has been historically
treated as an artifact, and modeled as a smoothed average to
obliterate the asymmetry of drug-induced suspension and
reanimation of consciousness [12,13,14]. Nonetheless, carefully
controlled clinical studies to definitively confirm anesthetic
hysteresis in steady-state conditions as evidence of a barrier to
anesthetic emergence are currently lacking. Evidence of barriers to
the return of wakefulness is known in the neurobiology of natural
human sleep. Studies show that humans may exhibit variable
periods of confusion, disorientation, and low arousal upon
awakening. This poorly understood phenomenon has been labeled
sleep inertia [36], which illustrates an intrinsic example of
naturally occurring resistance to changes in arousal state.
We show by direct measurement that the residual anesthetic in
mouse brain at the EC50 for induction is always greater than at the
EC50 for emergence and rebut the idea that measured inspired
anesthetic concentrations simply lag behind CNS tissue concen-
trations. However, the most convincing data to refute a
pharmacokinetic explanation come from studies in Drosophila.
Respiratory physiology in Drosophila simplifies the problem of
anesthetic uptake and delivery. Flies utilize a pure diffusion-based
respiratory system for gas exchange in which air enters directly
into their branching tracheal system that courses throughout the
entire organism [37]. While air entry and exit in Drosophila occurs
through sphincter-controlled openings called spiracles, these
portals are never fully closed. Although the fly has a primitive
circulatory system, it does not affect oxygen transport or carbon
dioxide removal [38]. Hence, in contrast to mammals, the fly
circulatory system should not affect anesthetic gas delivery.
Mathematical modeling based upon the volume of the cylinder
housing individual flies and the measured gas flow dictates that
Figure 6. Genetic Changes Also Modulate Neural Inertia In Flies. (A) Isoflurane dose-response curve in flies with a mutant Shaker potassium
channel, Sh
mns (gray circles) and sibling controls (black circles) is shown for induction (filled symbols, solid curves) and emergence (open symbols,
dotted curves). (B) Unpaired t-test demonstrates that neural inertia is significantly reduced in Sh
mns flies. X-axis in A corresponds to the log of the
inhaled anesthetic concentration.
**p,0.01.
doi:10.1371/journal.pone.0011903.g006
Table 3. Best fit parameters for isoflurane studies in
Drosophila carrying the Sh
mns mutation and their sibling
controls.
Sh
mns Sh control siblings
Induction Emergence Induction Emergence
EC50 (%atm) 0.49 0.47 0.39 0.27
95% C.I. (%atm) 0.48–0.51 0.44–0.49 0.38–0.40 0.25–0.30
Hill slope 27.8 27.5 29.6 25.7
95% C.I.
(%atm)
29.1 to
26.5
29.7 to
25.3
212.0 to
26.8
28.2 to
23.3
T o p 9 88 19 9 5 1
95% C.I. Top 93–100 76–86 93–100 46–56
doi:10.1371/journal.pone.0011903.t003
Behavioral State Barrier
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reached in seconds. Direct measurements of residual halothane in
whole flies studied under equilibrium conditions also show a
greater tissue concentration of halothane at the EC50 for induction
than at the EC50 for emergence. Still, the best evidence against a
pharmacokinetic explanation for our data comes from genetic
studies of Sh
mns flies where a single gene mutation collapses neural
inertia without any obvious effects on volatile anesthetic uptake,
distribution, or metabolism.
Modulation of neural inertia can occur by simultaneous
leftward or rightward shifts in both induction and emergence
curves, during which emergence is affected more than induction to
widen or narrow the hysteresis loop. These shifts can be induced
genetically as in the case of Dbh null mice, where absence of
adrenergic ligands results in marked increase in neural inertia
(Figure 5). This result is consistent with the observation that
adrenergic projections to the thalamus, hypothalamus, and basal
forebrain play a critical role in the regulation of arousal
[39,40,41,42]. One question that arises is whether increased
neural inertia in Dbh null mice is due to the loss of adrenergic
ligands in the periphery, CNS, or both. CNS specific rescue of
adrenergic signaling [26] restores the widened neural inertia of
Dbh null animals back to control levels, whereas vehicle treatment
does not. Notably, while CNS specific rescue leaves peripheral
tissues such as the heart, vasculature, and lungs devoid of
norepinephrine and epinephrine, restoration of adrenergic signal-
ing in brainstem respiratory and/or vasomotor centers could
partially confound an otherwise clean rescue. Arguing against this
latter indirect effect in the periphery is the observation that L-
DOPS restores brainstem levels of epinephrine and norepineph-
rine less efficiently than in forebrain [26].
Conversely neural inertia can be narrowed by genetic
manipulation as demonstrated by the effects of the mutant allele
Sh
mns in Drosophila. This result is consistent with work done in rats,
which demonstrated that microinjection of an antibody against the
Shaker potassium channel (Kv1.2) into the central medial
thalamus also reverses deep states of anesthetic-induced hypnosis
by abruptly triggering emergence, with signs of return to
consciousness, despite ongoing delivery of volatile anesthetics
[43]. Near-total collapse of neural inertia in Shaker mutant flies
raises concerns of additional anesthetic morbidity. Should they
exist, humans with similar low levels of neural inertia may be
predisposed to awareness under anesthesia.
In humans, case reports document profoundly delayed emergence
in a subset of narcoleptic patients without apparent changes in sensi-
tivity to induction of anesthesia [44,45]. Narcolepsy with cataplexy is
caused by a derangement of orexin (also known as hypocretin)
signaling [46,47]. Orexin-deficient mice exhibit normal sensitivity to
induction by isoflurane with delayed emergence from anesthesia,
pointing to an increase in neural inertia in these animals [48].
Our initial studies have focused upon candidate genes known to
affect the regulation of arousal state [49,50] and suspected to alter
induction of general anesthesia [23,24,27,28]. Whether altered
propensity to maintain wakefulness is a necessary condition of
altered neural inertia remains unknown, but eminently testable in
both mouse and fly models. Moreover, an opportunity exists to
exploit the power of genetics in Drosophila with the explicit purpose
of identifying novel genes that affect sensitivity to induction,
emergence, and the inertial barrier separating the two. Under-
standing the genes and neuronal circuits underlying resistance to
behavioral state changes will provide greater insights into
mechanisms of drug-induced suspension and reassembly of
cognition while also shedding light on the minimal neural
substrates required for arousal.
Materials and Methods
Ethics Statement
All studies were approved by the Institutional Animal Care and
Use Committee at the University of Pennsylvania (Philadelphia,
PA) #A3079-01 and were conducted in accordance with the
National Institutes of Health guidelines.
Righting Reflex Studies
48 10–12 week old male C57BL6/J mice (Jackson Laboratories,
Bar Harbor, ME) were used in this study. Following four days of
habituation, during which mice were exposed to 125 ml/min of
fresh oxygen flow in 250 ml cylindrical open circuit chambers for
2 hours, anesthetic testing began [51]. Beginning at zeitgeber time
(ZT) 0–2, mice were exposed to a single concentration of halothane
dissolved in 100% oxygen for 15 minutes before assessment of the
righting reflex was made. Initial and final halothane concentrations
were0.65% and 0.93% with 6 intermediate steps averaging 0.035%
apiece. After the last mouse had lost its righting reflex, halothane
concentration was decreased in twenty-three 15-minute intervals
that averaged 0.04% per step. For isoflurane experiments, average
initial and final concentrations were 0.67% and 1.02% with 8
intermediate steps averaging 0.035% apiece. To determine
emergence in mice, isoflurane concentration was decreased every
15 minutes using eleven 15-minute steps and an average decrease
of 0.04%. Anesthetic gas concentrations were determined in
triplicate using a Riken FI-21 refractometer. Body temperature
was maintained at 36.660.2uC by submerging the chambers in a
heated water bath. To minimize the number of animals required,
behavioral assessment of righting reflex was conducted with a single
anesthetic twice in all mice with one week between exposures.
Halothane and isoflurane induction-emergence curves were
generated from two independent cohorts of 24 mice. Assessment
of isoflurane sensitivity was also performed in Dbh heterozygous
(n=13) and null siblings (n=10) that have been maintained on a
hybrid C57BL/6J6129/SvCPJ genetic background [49]. Dbh
heterozygous females were mated to Dbh null males and treated
with 100 mg/ml each of phenylephrine and isoproterenol (Sigma,
St. Louis, MO) from embryonic day 8.5 to 16.5 and with 2 mg/ml
L-threo-3,4-dihydroxyphenylserine (L-DOPS, Sumitomo Pharma-
ceuticals, Osaka, Japan) from E16.5 to birth in the maternal
drinking water to enhance fetal survival [52]. As neither
norepinephrine nor epinephrine is essential for postnatal survival,
litters were not treated after birth. Mice ranged in age from 4–6
months and included equal numbers of males and females.
Pharmacologic rescue of catecholamine signaling in Dbh
null mice
Rescue of adrenergic signaling in Dbh null mice was performed
in accordance with published protocols [26,49]. Five hours prior
to beginning anesthetic sensitivity testing, mice received a
subcutaneous injection of 20 mg/ml pH neutralized L-DOPS
plus 2 mg/ml vitamin C (Sigma, St. Louis, MO) and 1 mg/ml of
the peripheral aromatic L-amino acid decarboxylase inhibitor,
benserazide (Sigma, St. Louis, MO), in a final volume of 50 ml/g.
Such treatment has been shown to restore near-normal levels for
12 hours with levels peaking roughly 5 hours after injection [26].
To control for the stress of injection, half the animals received a
subcutaneous injection of vehicle 50 ml/g 5 hours prior to
behavioral testing.
Behavioral assessment of anesthetic action in Drosophila
Fly strains used were Iso31 (an isogenic w
1118 strain) and RC1.
Flies with the Sh
mns mutation were provided by Dr. Chiara Cirelli
Behavioral State Barrier
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background. Flies were housed under 12:12 hr Light:Dark
conditions and maintained under standard conditions [53]. Two
to three days post eclosion, adult female flies were anesthetized
with carbon dioxide and placed into 65mm65mm cylindrical
tubes containing 5% sucrose and 2% agar and entrained for
24 hours. Baseline locomotor/rest activity was then measured for
24 hours using a locomotor monitoring system (Trikinetics,
Waltham, MA). Experiments were conducted during the evening
locomotor activity peak (ZT10.5 to ZT13) [20,21]. Anesthetics
dissolved in air were delivered to flies in parallel circuit design
[51]. Anesthetic gas concentration was measured as described
above. To exclude endogenous sleep and/or hypothermia (as
continuous gas flows through the DAMS tubes) as sources of
inactivity, locomotor activity of non-anesthetized control flies
receiving air was simultaneously measured. Flies were exposed to a
set of 5-minute stepwise increases followed by decreases in
anesthetic concentration. Fresh gas flow was measured with a
mass flowmeter (Omega, Stamford, CT) and set at 15 ml/min/
tube. Based upon a measured tube volume of 0.75ml, each
cylindrical tube housing a single fly should reach equilibrium
within 18 seconds. Activity counts were summed over all
5 minutes spent at a single anesthetic concentration. Counts for
each individual fly were transformed to a binary output of 0,
signifying no activity, or 1, indicating movement. Flies that did not
move in the 15 minutes prior to the start of anesthesia or during
the first 5 minutes at the lowest anesthetic dose were excluded
from subsequent analysis. Flies that did not recover activity during
the 24 hours following anesthesia were also excluded from
analysis. In total less than 2% of flies were excluded, Table S1.
Tissue measurements of volatile anesthetic
concentration in mouse brain or whole fly
1–2 weeks after the second determination of the population’s
EC50 for induction and emergence, a subset of mice from each
original cohort (isoflurane, n=18; halothane, n=16) were
exposed to an identical anesthetic ramp-up and down protocol
for the third time. At the EC50 dose for induction, half of the mice
were sacrificed while the remaining half continued in the dosing
protocol, until all mice had lost their righting reflex. Subsequently,
isoflurane or halothane levels were decreased in 15-minute steps
until the EC50 for emergence was reached when the remaining
mice were sacrificed. Upon sacrifice, whole brains were processed
as previously described [48]. To determine halothane levels in flies
at the EC50 doses for induction and emergence, populations of 100
flies were simultaneously exposed to halothane using an identical
concentration ramp in the barrel of a 10ml syringe. At the EC50
corresponding to induction (5 groups) of anesthesia, flies were snap
frozen in liquid nitrogen. A second cohort of flies (4 groups)
underwent a full induction and following peak halothane
concentration, decreasing doses were delivered. At the EC50 for
emergence flies were snap frozen in liquid nitrogen. Groups of
whole flies were homogenized and measured by HPLC as
described as previously described. Unlike mice, whole fly
homogenates cannot be assumed to yield central concentrations.
Statistical analyses
Induction and emergence curves were fit with a sigmoidal dose-
response and variable slope function (Prism 4.0c, GraphPad
Software Inc., San Diego, CA) as described [48,51]. Each curve
depicts the best-fit data for two to four replicates (mice) or three to
six replicates (Drosophila) of the corresponding wild type or mutant
populations. For murine studies, ‘‘bottom’’ and ‘‘top’’ parameters
were constrained to 0 and 100 respectively. In Drosophila studies,
‘‘bottom’’ was constrained to 0, while the ‘‘top’’ was not
constrained. No constraints were placed on the Hill slope, EC50,
or log(EC50) fit parameters. All values are reported along with
their corresponding 95% confidence intervals. To calculate neural
inertia, both induction and emergence sigmoidal dose-response
curves were mathematically integrated over the range of the
induction curve’s EC1 to the emergence curve’s EC99 correspond-
ing to the concentrations at which 99% of the population had
entered or exited from the anesthetic state. Neural inertia for each
set of induction and emergence curves is expressed as the mean 6
standard error. (Appendix S1) Comparison of neural inertia
between wild type and mutants is reported using a t-test or one-
way ANOVA as appropriate. Anesthetic concentrations in whole
fly or mouse brain are reported as the average 6 standard error
with significance determined by t-tests.
Supporting Information
Table S1 Number of Study Subjects.
Found at: doi:10.1371/journal.pone.0011903.s001 (0.03 MB
DOC)
Figure S1 Graphical Depictions Of Neural Inertia Arising With
Different Hill Slope, LogEC50, And Top Best-Fit Parameters.
Neural inertia is shown in red and defined by the area bounded
between the induction and emergence curves over the X-range
corresponding to the emergence EC99 (denoted by the dashed
vertical line labeled E99) through the induction EC1 (denoted by
the solid vertical line labeled I1). Due to hysteresis that separates the
induction and emergence curves, the E99?I99 and the E1?I1.
Found at: doi:10.1371/journal.pone.0011903.s002 (0.31 MB TIF)
Figure S2 Neural Inertia In Wild Type RC1 Drosophila Strain.
RC1 flies have the wild type w gene allele. Filled circles and their
corresponding best-fit solid curve denote induction. Open circles
and their corresponding best-fit dashed curve denote emergence.
(A) Isoflurane induction and emergence dose-response curves in
RC1 flies. (B) Halothane induction and emergence dose-response
curves in RC1 flies. (C) Neural inertia in RC1 flies.
Found at: doi:10.1371/journal.pone.0011903.s003 (0.77 MB TIF)
Appendix S1 Derivation of Neural Inertia.
Found at: doi:10.1371/journal.pone.0011903.s004 (0.06 MB
DOC)
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